JT
John Temperato
Chief Executive OfficerDirector

John Temperato insider trades: 9 Meters Biopharma (NMTR) stock purchases

Chief Executive Officer, 9 Meters Biopharma Last trade Jul 6, 2022 20 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2020
1
Company
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where John reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 6, 2022NMTR↑ Buy$28K
May 18, 2022NMTR↑ Buy$22K
Mar 3, 2022NMTR↑ Buy$56K
Nov 18, 2021NMTR↑ Buy$53K
Aug 18, 2021NMTR↑ Buy$26K
Apr 5, 2021NMTR↑ Buy$100K
Dec 15, 2020NMTR↑ Buy$100K
Aug 21, 2020NMTR↑ Buy$48K
Aug 17, 2020NMTR↑ Buy$20K
Jun 15, 2020NMTR↑ Buy$6K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About John Temperato's insider trades

John Temperato is Chief Executive Officer at 9 Meters Biopharma (NMTR). Since Jun 15, 2020, John has reported 10 open-market purchases worth $459K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (7 filings), other transactions (3 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NMTR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.